BriaCell Therapeutics Corp Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CABLE CAR CAPITAL LLC | 08/14/2026 | 216.82 K | $702.50 K | 0.00% | 2.99% |
| SABBY MANAGEMENT, LLC | 08/14/2026 | 80.72 K | $261.54 K | 9.21% | 1.11% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 07/29/2026 | 65.00 K | $210.60 K | 0.00% | 0.90% |
| UBS GROUP AG | 08/13/2026 | 43.64 K | $141.40 K | 278.15% | 0.60% |
| HRT FINANCIAL LP | 08/14/2026 | 34.90 K | $113.00 K | 100.00% | 0.48% |
| JANE STREET GROUP, LLC | 08/14/2026 | 26.52 K | $85.91 K | 100.00% | 0.37% |
| LUMINARX CAPITAL MANAGEMENT LP | 08/14/2026 | 25.00 K | $22.25 K | 100.00% | 0.34% |
| LUMINARX CAPITAL MANAGEMENT LP | 08/14/2026 | 15.00 K | $48.60 K | 0.00% | 0.21% |
| NATIONAL BANK OF CANADA /FI/ | 08/10/2026 | 1.80 K | $5.80 K | 124.81% | 0.02% |
| MORGAN STANLEY | 08/13/2026 | 1.03 K | $3.35 K | -65.81% | 0.01% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/14/2026 | 450 | $1.44 K | -1.10% | 0.01% |
| ROYAL BANK OF CANADA | 08/14/2026 | 289 | $1.00 K | 100.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 08/11/2026 | 100 | $324 | 0.00% | 0.00% |
| SSA SWISS ADVISORS AG | 08/05/2026 | 37 | $121 | 100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 34 | $110 | 385.71% | 0.00% |
| TD WATERHOUSE CANADA INC. | 07/27/2026 | 19 | $66 | 0.00% | 0.00% |
| GROUP ONE TRADING, L.P. | 08/14/2026 | 16 | $52 | 0.00% | 0.00% |
| HHM WEALTH ADVISORS, LLC | 07/13/2026 | 6 | $20 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 1 | $3 | 0.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
BriaCell Therapeutics Corp institutional Ownership - FAQ's
During the previous two years, 19 institutional investors and hedge funds held shares of BriaCell Therapeutics Corp. The most heavily invested institutionals were:
Cable Car Capital LLC: 216,821
SABBY MANAGEMENT, LLC: 80,721
IRIDIAN ASSET MANAGEMENT LLC/CT: 65,000
UBS Group AG: 43,642
HRT FINANCIAL LP: 34,904
JANE STREET GROUP, LLC: 26,515
6.71% of BriaCell Therapeutics Corp stock is owned by institutional investors.
Institutional investors have bought a total of 486.39 K shares in the last 24 months. This purchase volume represents approximately $1.83 M in transactions.